Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
346,7 USD | -0,80% | -0,19% | -24,27% |
22/03 | HUMANA INC. : Raymond James blijft neutraal | ZM |
20/03 | Humana werkt samen met DUOS aan gezondheidszorg voor veteranen in Louisiana | MT |
Filters: Beursproducten
Beurs
Noord-Amerika
Zuid-Amerika
Europa
Afrika
Midden-Oosten
Azië
Oceanië
Centraal-Amerika
Uitgever
Product
Type
Looptijd
Alleen beschikbaar voor producten met hefboomwerking
Hefboom / Elasticiteit
Beursproducten
Mnemo | Type | Product | Looptijd | Elasticiteit | Hefboom | Pariteit | Koers | Uitgever | ||
---|---|---|---|---|---|---|---|---|---|---|
PUT
| PUT | Certificat Turbo | Onbeperkt | - | 10 | 33,82 EUR |
Vontobel
| |||
PUT
| PUT | Certificat Turbo Stop Loss | Onbeperkt | - | 10 | 32,87 EUR |
Vontobel
| |||
PUT
| PUT | Certificat Turbo | Onbeperkt | - | 10 | 32,78 EUR |
Vontobel
| |||
PUT
| PUT | Certificat Turbo Stop Loss | Onbeperkt | - | 10 | 30,86 EUR |
Vontobel
| |||
PUT
| PUT | Certificat Turbo | Onbeperkt | - | 10 | 30,97 EUR |
Vontobel
| |||
PUT
| PUT | Certificat Turbo | Onbeperkt | - | 10 | 48,77 EUR |
Goldman Sachs
| |||
CALL
| CALL | Warrants | 17-01-2025 | 4.15x | - | 100 | 0,001 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 17-01-2025 | 4.6x | - | 100 | 0,001 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 17-01-2025 | 4.65x | - | 100 | 0,002 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 17-01-2025 | 4.72x | - | 100 | 0,002 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 17-01-2025 | 4.79x | - | 100 | 0,002 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 17-01-2025 | 4.87x | - | 100 | 0,002 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 17-01-2025 | 4.95x | - | 100 | 0,002 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 21-06-2024 | 8.25x | - | 100 | 0,001 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 17-01-2025 | 5.03x | - | 100 | 0,003 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 21-06-2024 | 8.45x | - | 100 | 0,001 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 17-01-2025 | 5.13x | - | 100 | 0,003 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 21-06-2024 | 8.67x | - | 100 | 0,001 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 20-09-2024 | 5.11x | - | 100 | 0.15 0.001 |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 17-01-2025 | 5.23x | - | 100 | 0,004 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 21-06-2024 | 8.94x | - | 100 | 0,001 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 20-09-2024 | 5.22x | - | 100 | 0.15 0.001 |
J.P. Morgan
| ||
PUT
| PUT | Certificat Turbo Stop Loss | Onbeperkt | - | 10 | 29,98 EUR |
Vontobel
| |||
CALL
| CALL | Warrants | 17-01-2025 | 5.89x | - | 100 | 0,005 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 21-06-2024 | 9.09x | - | 100 | 0,001 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 20-09-2024 | 6.08x | - | 100 | 0.1 0.001 |
J.P. Morgan
| ||
PUT
| PUT | Certificat Turbo | Onbeperkt | - | 10 | 29,11 EUR |
Vontobel
| |||
PUT
| PUT | Certificat Turbo Stop Loss | Onbeperkt | - | 10 | 28,91 EUR |
Vontobel
| |||
PUT
| PUT | Certificat Turbo | Onbeperkt | - | 10 | 28,07 EUR |
Vontobel
| |||
PUT
| PUT | Certificat Turbo Stop Loss | Onbeperkt | - | 10 | 28,02 EUR |
Vontobel
| |||
CALL
| CALL | Warrants | 17-01-2025 | 6.03x | - | 100 | 0,006 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 21-06-2024 | 9.58x | - | 100 | 0,001 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 17-05-2024 | 10.03x | - | 100 | 0,001 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 20-09-2024 | 6.23x | - | 100 | 0.1 0.002 |
J.P. Morgan
| ||
PUT
| PUT | Certificat Turbo | Onbeperkt | - | 10 | 27,13 EUR |
Vontobel
| |||
PUT
| PUT | Certificat Turbo Stop Loss | Onbeperkt | - | 10 | 27,02 EUR |
Vontobel
| |||
PUT
| PUT | Certificat Turbo | Onbeperkt | - | 10 | 26,26 EUR |
Vontobel
| |||
PUT
| PUT | Certificat Turbo Stop Loss | Onbeperkt | - | 10 | 25,97 EUR |
Vontobel
| |||
CALL
| CALL | Warrants | 17-01-2025 | 6.17x | - | 100 | 0,008 EUR |
J.P. Morgan
| ||
CALL
| CALL | Warrants | 21-06-2024 | 9.86x | - | 100 | 0,001 EUR |
J.P. Morgan
| ||
- Beurs
- Aandelen
- Aandeel Humana Inc. - Nyse
- Derivaten Humana Inc.